The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2015

Filed:

Apr. 19, 2013
Applicant:

Becton, Dickinson and Company, Franklin Lakes, NJ (US);

Inventors:

Ronald J. Pettis, Cary, NC (US);

James A. Down, Randolph, NJ (US);

Noel G. Harvey, Efland, NC (US);

Assignee:

Becton, Dickinson and Company, Franklin Lakes, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61M 5/158 (2006.01); A61M 5/32 (2006.01); A61M 5/46 (2006.01); A61M 37/00 (2006.01);
U.S. Cl.
CPC ...
A61M 5/158 (2013.01); A61M 5/32 (2013.01); A61M 5/3286 (2013.01); A61M 5/3291 (2013.01); A61M 5/46 (2013.01); A61M 37/0015 (2013.01); A61M 2037/0038 (2013.01); A61M 2037/0061 (2013.01);
Abstract

The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.


Find Patent Forward Citations

Loading…